Cargando…
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
Sensitive and reliable protein biomarkers are needed to predict disease trajectory and personalize treatment strategies for multiple sclerosis (MS). Here, we use the highly sensitive proximity-extension assay combined with next-generation sequencing (Olink Explore) to quantify 1463 proteins in cereb...
Autores principales: | Åkesson, Julia, Hojjati, Sara, Hellberg, Sandra, Raffetseder, Johanna, Khademi, Mohsen, Rynkowski, Robert, Kockum, Ingrid, Altafini, Claudio, Lubovac-Pilav, Zelmina, Mellergård, Johan, Jenmalm, Maria C., Piehl, Fredrik, Olsson, Tomas, Ernerudh, Jan, Gustafsson, Mika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616092/ https://www.ncbi.nlm.nih.gov/pubmed/37903821 http://dx.doi.org/10.1038/s41467-023-42682-9 |
Ejemplares similares
-
Prominent epigenetic and transcriptomic changes in CD4(+) and CD8(+) T cells during and after pregnancy in women with multiple sclerosis and controls
por: Zenere, Alberto, et al.
Publicado: (2023) -
ComHub: Community predictions of hubs in gene regulatory networks
por: Åkesson, Julia, et al.
Publicado: (2021) -
RNA-sequencing and mass-spectrometry proteomic time-series analysis of T-cell differentiation identified multiple splice variants models that predicted validated protein biomarkers in inflammatory diseases
por: Magnusson, Rasmus, et al.
Publicado: (2022) -
Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy
por: Papapavlou Lingehed, Georgia, et al.
Publicado: (2022) -
MODalyseR—a novel software for inference of disease module hub regulators identified a putative multiple sclerosis regulator supported by independent eQTL data
por: de Weerd, Hendrik A, et al.
Publicado: (2022)